 | • レポートコード：QY20ST-06615 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の閉経薬市場について種類別（非経口、経皮、経口、その他）、用途別（病院、ドラッグストア、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・閉経薬市場の概要 ・世界の主要地域別閉経薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の閉経薬市場規模2015-2026：種類別（非経口、経皮、経口、その他） ・世界の閉経薬市場規模2015-2026：用途別（病院、ドラッグストア、その他） ・閉経薬の北米市場規模2015-2020 ・閉経薬のヨーロッパ市場規模2015-2020 ・閉経薬の中国市場規模2015-2020 ・閉経薬の日本市場規模2015-2020 ・閉経薬の東南アジア市場規模2015-2020 ・閉経薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・閉経薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・閉経薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Menopause Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Menopause Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Menopause is the end of a woman’s menstrual cycles. The term can describe any of the changes you go through just before or after you stop having your period, marking the end of your reproductive years.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Menopause Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Menopause Drugs industry.
Based on our recent survey, we have several different scenarios about the Menopause Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Menopause Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Menopause Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Menopause Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Menopause Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Menopause Drugs market. The report also includes nautical information, where it shows Menopause Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Menopause Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Menopause Drugs market.
Geographical Analysis:
Based on region, the global Menopause Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Menopause Drugs market are
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD
Segment by Type
Parenteral
Transdermal
Oral
Others
Segment by Application
Hospitals
Drugstores
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Menopause Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Menopause Drugs market.
• The market share of the global Menopause Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Menopause Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Menopause Drugs market.
1 Menopause Drugs Market Overview
1.1 Menopause Drugs Product Scope
1.2 Menopause Drugs Segment by Type
1.2.1 Global Menopause Drugs Sales by Type (2020-2026)
1.2.2 Parenteral
1.2.3 Transdermal
1.2.4 Oral
1.2.5 Others
1.3 Menopause Drugs Segment by Application
1.3.1 Global Menopause Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Menopause Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Menopause Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Menopause Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Menopause Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Menopause Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Menopause Drugs Industry
1.5.1.1 Menopause Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Menopause Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Menopause Drugs Players to Combat Covid-19 Impact
2 Menopause Drugs Estimate and Forecast by Region
2.1 Global Menopause Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Menopause Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Menopause Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Menopause Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Menopause Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Menopause Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Menopause Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Menopause Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Menopause Drugs Estimates and Projections (2015-2026)
2.4.3 China Menopause Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Menopause Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Menopause Drugs Estimates and Projections (2015-2026)
2.4.6 India Menopause Drugs Estimates and Projections (2015-2026)
3 Global Menopause Drugs Competition Landscape by Players
3.1 Global Top Menopause Drugs Players by Sales (2015-2020)
3.2 Global Top Menopause Drugs Players by Revenue (2015-2020)
3.3 Global Menopause Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Menopause Drugs as of 2019)
3.4 Global Menopause Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Menopause Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Menopause Drugs Players (Opinion Leaders)
4 Global Menopause Drugs Market Size by Type
4.1 Global Menopause Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Menopause Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Menopause Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Menopause Drugs Price by Type (2014-2020)
4.2 Global Menopause Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Menopause Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Menopause Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Menopause Drugs Price Forecast by Type (2021-2026)
5 Global Menopause Drugs Market Size by Application
5.1 Global Menopause Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Menopause Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Menopause Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Menopause Drugs Price by Application (2015-2020)
5.2 Global Menopause Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Menopause Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Menopause Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Menopause Drugs Price Forecast by Application (2021-2026)
3 North America Menopause Drugs Market Facts & Figures
3.2 North America Menopause Drugs Sales Market Share by Company (2015-2020)
3.3 North America Menopause Drugs Sales Market Share by Type (2015-2020)
3.4 North America Menopause Drugs Sales Market Share by Application (2015-2020)
4 Europe Menopause Drugs Market Facts & Figures
4.2 Europe Menopause Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Menopause Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Menopause Drugs Sales Market Share by Application (2015-2020)
5 China Menopause Drugs Market Facts & Figures
5.2 China Menopause Drugs Sales Market Share by Company (2015-2020)
5.3 China Menopause Drugs Sales Market Share by Type (2015-2020)
5.4 China Menopause Drugs Sales Market Share by Application (2015-2020)
6 Japan Menopause Drugs Market Facts & Figures
6.2 Japan Menopause Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Menopause Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Menopause Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Menopause Drugs Market Facts & Figures
7.2 Southeast Asia Menopause Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Menopause Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Menopause Drugs Sales Market Share by Application (2015-2020)
8 India Menopause Drugs Market Facts & Figures
8.2 India Menopause Drugs Sales Market Share by Company (2015-2020)
8.3 India Menopause Drugs Sales Market Share by Type (2015-2020)
8.4 India Menopause Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Menopause Drugs Business
12.1 Eli Lilly
12.1.1 Eli Lilly Menopause Drugs Corporation Information
12.1.2 Eli Lilly Menopause Drugs Business Overview and Total Revenue
12.1.3 Eli Lilly Menopause Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Eli Lilly Menopause Drugs Products Offered
12.1.5 Eli Lilly Recent Development
12.2 Pfizer
12.2.1 Pfizer Menopause Drugs Corporation Information
12.2.2 Pfizer Menopause Drugs Business Overview and Total Revenue
12.2.3 Pfizer Menopause Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Menopause Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 AbbVie
12.3.1 AbbVie Menopause Drugs Corporation Information
12.3.2 AbbVie Menopause Drugs Business Overview and Total Revenue
12.3.3 AbbVie Menopause Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AbbVie Menopause Drugs Products Offered
12.3.5 AbbVie Recent Development
12.4 Novo Nordisk
12.4.1 Novo Nordisk Menopause Drugs Corporation Information
12.4.2 Novo Nordisk Menopause Drugs Business Overview and Total Revenue
12.4.3 Novo Nordisk Menopause Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novo Nordisk Menopause Drugs Products Offered
12.4.5 Novo Nordisk Recent Development
12.5 Merck KGaA
12.5.1 Merck KGaA Menopause Drugs Corporation Information
12.5.2 Merck KGaA Menopause Drugs Business Overview and Total Revenue
12.5.3 Merck KGaA Menopause Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Merck KGaA Menopause Drugs Products Offered
12.5.5 Merck KGaA Recent Development
12.6 Mylan
12.6.1 Mylan Menopause Drugs Corporation Information
12.6.2 Mylan Menopause Drugs Business Overview and Total Revenue
12.6.3 Mylan Menopause Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mylan Menopause Drugs Products Offered
12.6.5 Mylan Recent Development
12.7 Bayer
12.7.1 Bayer Menopause Drugs Corporation Information
12.7.2 Bayer Menopause Drugs Business Overview and Total Revenue
12.7.3 Bayer Menopause Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bayer Menopause Drugs Products Offered
12.7.5 Bayer Recent Development
12.8 Teva
12.8.1 Teva Menopause Drugs Corporation Information
12.8.2 Teva Menopause Drugs Business Overview and Total Revenue
12.8.3 Teva Menopause Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Teva Menopause Drugs Products Offered
12.8.5 Teva Recent Development
12.9 Novartis
12.9.1 Novartis Menopause Drugs Corporation Information
12.9.2 Novartis Menopause Drugs Business Overview and Total Revenue
12.9.3 Novartis Menopause Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Novartis Menopause Drugs Products Offered
12.9.5 Novartis Recent Development
12.10 Abbott
12.10.1 Abbott Menopause Drugs Corporation Information
12.10.2 Abbott Menopause Drugs Business Overview and Total Revenue
12.10.3 Abbott Menopause Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Abbott Menopause Drugs Products Offered
12.10.5 Abbott Recent Development
12.11 Roche
12.11.1 Roche Menopause Drugs Corporation Information
12.11.2 Roche Menopause Drugs Business Overview and Total Revenue
12.11.3 Roche Menopause Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Roche Menopause Drugs Products Offered
12.11.5 Roche Recent Development
12.12 Endo International
12.12.1 Endo International Menopause Drugs Corporation Information
12.12.2 Endo International Menopause Drugs Business Overview and Total Revenue
12.12.3 Endo International Menopause Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Endo International Menopause Drugs Products Offered
12.12.5 Endo International Recent Development
12.13 Ipsen
12.13.1 Ipsen Menopause Drugs Corporation Information
12.13.2 Ipsen Menopause Drugs Business Overview and Total Revenue
12.13.3 Ipsen Menopause Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Ipsen Menopause Drugs Products Offered
12.13.5 Ipsen Recent Development
12.14 ANI Pharmaceuticals
12.14.1 ANI Pharmaceuticals Menopause Drugs Corporation Information
12.14.2 ANI Pharmaceuticals Menopause Drugs Business Overview and Total Revenue
12.14.3 ANI Pharmaceuticals Menopause Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 ANI Pharmaceuticals Menopause Drugs Products Offered
12.14.5 ANI Pharmaceuticals Recent Development
12.15 TherapeuticsMD
12.15.1 TherapeuticsMD Menopause Drugs Corporation Information
12.15.2 TherapeuticsMD Menopause Drugs Business Overview and Total Revenue
12.15.3 TherapeuticsMD Menopause Drugs Sales, Revenue and Gross Margin (2015-2020)
12.15.4 TherapeuticsMD Menopause Drugs Products Offered
12.15.5 TherapeuticsMD Recent Development
13 Menopause Drugs Manufacturing Cost Analysis
13.1 Menopause Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Menopause Drugs
13.4 Menopause Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Menopause Drugs Distributors List
14.3 Menopause Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Menopause Drugs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Menopause Drugs Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Menopause Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Menopause Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Menopause Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Menopause Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Menopause Drugs Sales (K Units) by Region (2015-2020)
Table 10. Global Menopause Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Menopause Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Menopause Drugs Revenue Share by Region (2015-2020)
Table 13. Global Menopause Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Menopause Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Menopause Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Menopause Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Menopause Drugs (K Units) of Key Companies (2015-2020)
Table 18. Global Menopause Drugs Sales Share by Company (2015-2020)
Table 19. Global Menopause Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Menopause Drugs Revenue Share by Company (2015-2020)
Table 21. Global Menopause Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Menopause Drugs as of 2019)
Table 22. Global Menopause Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Menopause Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Menopause Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Menopause Drugs Players
Table 27. Global Menopause Drugs Sales (K Units) by Type (2015-2020)
Table 28. Global Menopause Drugs Sales Share by Type (2015-2020)
Table 29. Global Menopause Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Menopause Drugs Price (K Units) by Type (2015-2020)
Table 31. Global Menopause Drugs Sales Share by Type (2021-2026)
Table 32. Global Menopause Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Menopause Drugs Revenue Share by Type (2021-2026)
Table 34. Global Menopause Drugs Price (K Units) by Type (2021-2026)
Table 35. Global Menopause Drugs Sales (K Units) by Application (2015-2020)
Table 36. Global Menopause Drugs Sales Share by Application (2015-2020)
Table 37. Global Menopause Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Menopause Drugs Price (K Units) by Application (2015-2020)
Table 39. Global Menopause Drugs Sales (K Units) by Application (2021-2026)
Table 40. Global Menopause Drugs Sales Share by Application (2021-2026)
Table 41. Global Menopause Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Menopause Drugs Revenue Share by Application (2021-2026)
Table 43. Global Menopause Drugs Price (K Units) by Application (2021-2026)
Table 44. United States Menopause Drugs Sales (K Units) by Company (2015-2020)
Table 45. United States Menopause Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Menopause Drugs Sales (K Units) by Type (2015-2020)
Table 47. United States Menopause Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Menopause Drugs Sales (K Units) by Application (2015-2020)
Table 49. United States Menopause Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Menopause Drugs Sales (K Units) by Company (2015-2020)
Table 51. Europe Menopause Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Menopause Drugs Sales (K Units) by Type (2015-2020)
Table 53. Europe Menopause Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Menopause Drugs Sales (K Units) by Application (2015-2020)
Table 55. Europe Menopause Drugs Sales Market Share by Type (2015-2020)
Table 56. China Menopause Drugs Sales (K Units) by Company (2015-2020)
Table 57. China Menopause Drugs Sales Market Share by Company (2015-2020)
Table 58. China Menopause Drugs Sales (K Units) by Type (2015-2020)
Table 59. China Menopause Drugs Sales Market Share by Type (2015-2020)
Table 60. China Menopause Drugs Sales (K Units) by Application (2015-2020)
Table 61. China Menopause Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Menopause Drugs Sales (K Units) by Company (2015-2020)
Table 63. Japan Menopause Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Menopause Drugs Sales (K Units) by Type (2015-2020)
Table 65. Japan Menopause Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Menopause Drugs Sales (K Units) by Application (2015-2020)
Table 67. Japan Menopause Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Menopause Drugs Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Menopause Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Menopause Drugs Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Menopause Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Menopause Drugs Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Menopause Drugs Sales Market Share by Application (2015-2020)
Table 74. India Menopause Drugs Sales (K Units) by Company (2015-2020)
Table 75. India Menopause Drugs Sales Market Share by Company (2015-2020)
Table 76. India Menopause Drugs Sales (K Units) by Type (2015-2020)
Table 77. India Menopause Drugs Sales Market Share by Type (2015-2020)
Table 78. India Menopause Drugs Sales (K Units) by Application (2015-2020)
Table 79. India Menopause Drugs Sales Market Share by Application (2015-2020)
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Menopause Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Eli Lilly Menopause Drugs Product
Table 84. Eli Lilly Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Menopause Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Pfizer Menopause Drugs Product
Table 89. Pfizer Recent Development
Table 90. AbbVie Corporation Information
Table 91. AbbVie Description and Business Overview
Table 92. AbbVie Menopause Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. AbbVie Menopause Drugs Product
Table 94. AbbVie Recent Development
Table 95. Novo Nordisk Corporation Information
Table 96. Novo Nordisk Description and Business Overview
Table 97. Novo Nordisk Menopause Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Novo Nordisk Menopause Drugs Product
Table 99. Novo Nordisk Recent Development
Table 100. Merck KGaA Corporation Information
Table 101. Merck KGaA Description and Business Overview
Table 102. Merck KGaA Menopause Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Merck KGaA Menopause Drugs Product
Table 104. Merck KGaA Recent Development
Table 105. Mylan Corporation Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Menopause Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Mylan Menopause Drugs Product
Table 109. Mylan Recent Development
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Business Overview
Table 112. Bayer Menopause Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Bayer Menopause Drugs Product
Table 114. Bayer Recent Development
Table 115. Teva Corporation Information
Table 116. Teva Menopause Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Teva Description and Business Overview
Table 118. Teva Menopause Drugs Product
Table 119. Teva Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Menopause Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Novartis Description and Business Overview
Table 123. Novartis Menopause Drugs Product
Table 124. Novartis Recent Development
Table 125. Abbott Corporation Information
Table 126. Abbott Description and Business Overview
Table 127. Abbott Menopause Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Abbott Menopause Drugs Product
Table 129. Abbott Recent Development
Table 130. Roche Corporation Information
Table 131. Roche Description and Business Overview
Table 132. Roche Menopause Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Roche Menopause Drugs Product
Table 134. Roche Recent Development
Table 135. Endo International Corporation Information
Table 136. Endo International Description and Business Overview
Table 137. Endo International Menopause Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Endo International Menopause Drugs Product
Table 139. Endo International Recent Development
Table 140. Ipsen Corporation Information
Table 141. Ipsen Description and Business Overview
Table 142. Ipsen Menopause Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Ipsen Menopause Drugs Product
Table 144. Ipsen Recent Development
Table 145. ANI Pharmaceuticals Corporation Information
Table 146. ANI Pharmaceuticals Description and Business Overview
Table 147. ANI Pharmaceuticals Menopause Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. ANI Pharmaceuticals Menopause Drugs Product
Table 149. ANI Pharmaceuticals Recent Development
Table . TherapeuticsMD Corporation Information
Table . TherapeuticsMD Description and Business Overview
Table . TherapeuticsMD Menopause Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . TherapeuticsMD Menopause Drugs Product
Table . TherapeuticsMD Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Menopause Drugs Distributors List
Table 158. Menopause Drugs Customers List
Table 159. Market Key Trends
Table 160. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 161. Key Challenges
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Menopause Drugs Product Picture
Figure 2. Global Menopause Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Menopause Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Drugstores Examples
Figure 8. Others Examples
Figure 9. Global Menopause Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Menopause Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Menopause Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Menopause Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Menopause Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Menopause Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Menopause Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Menopause Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Menopause Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Menopause Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Menopause Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Menopause Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Menopause Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Menopause Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Menopause Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Menopause Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Menopause Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Menopause Drugs Players Market Share by Revenue in Menopause Drugs 2015 & 2019
Figure 27. Menopause Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Menopause Drugs Revenue Share by Type (2015-2020)
Figure 29. Global Menopause Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Menopause Drugs Revenue Share by Application (2015-2020)
Figure 31. Global Menopause Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Menopause Drugs Sales Market Share by Type in 2019
Figure 33. United States Menopause Drugs Sales Market Share by Type in 2019
Figure 34. Europe Menopause Drugs Sales Market Share by Company in 2019
Figure 35. Europe Menopause Drugs Sales Market Share by Type in 2019
Figure 36. Europe Menopause Drugs Sales Market Share by Application in 2019
Figure 37. China Menopause Drugs Sales Market Share by Company in 2019
Figure 38. China Menopause Drugs Sales Market Share by Type in 2019
Figure 39. China Menopause Drugs Sales Market Share by Application in 2019
Figure 40. Japan Menopause Drugs Sales Market Share by Company in 2019
Figure 41. Japan Menopause Drugs Sales Market Share by Type in 2019
Figure 42. Japan Menopause Drugs Sales Market Share by Application in 2019
Figure 43. Southeast Asia Menopause Drugs Sales Market Share by Company in 2019
Figure 44. Southeast Asia Menopause Drugs Sales Market Share by Type in 2019
Figure 45. Southeast Asia Menopause Drugs Sales Market Share by Application in 2019
Figure 46. India Menopause Drugs Sales Market Share by Company in 2019
Figure 47. India Menopause Drugs Sales Market Share by Type in 2019
Figure 48. India Menopause Drugs Sales Market Share by Application in 2019
Figure 49. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Ipsen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. ANI Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. TherapeuticsMD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Key Raw Materials Price Trend
Figure 65. Manufacturing Cost Structure of Menopause Drugs
Figure 66. Manufacturing Process Analysis of Menopause Drugs
Figure 67. Menopause Drugs Industrial Chain Analysis
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. Porter's Five Forces Analysis
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
ホルモン補充薬の世界市場レポート2020 A recently published report by QY Research titled Global Drugs For Hormonal Replacement Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provi…- ホルモン補充薬の世界市場レポート2020 A recently published report by QY Research titled Global Drugs For Hormonal Replacement Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provi…
- 非経口薬の世界市場レポート2020 A recently published report by QY Research titled Global Parenteral Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate d…
- 抗コリン性乗り物酔い薬の世界市場レポート2020 A recently published report by QY Research titled Global Anticholinergic Travel Sickness Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statisticall…
- 甲状腺機能低下症薬の世界市場レポート2020 A recently published report by QY Research titled Global Hypothyroidism Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accura…